ADC Therapeutics SA (ADCT) Retained Earnings (Accumulated Deficit) USD 2022 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
ADC Therapeutics SA quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2022 to 2023.
  • ADC Therapeutics SA Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was -$1.34 B, a 21.9% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 -$1.34 B -$240 M -21.9% Dec 31, 2023 10-K 2024-03-13
Q4 2022 -$1.1 B Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.